What is toujeo?

Toujeo is a brand name for insulin glargine, which is a long-lasting insulin medication used to control blood sugar levels in people with diabetes. Toujeo is produced by Sanofi, a global pharmaceutical company.

Toujeo is administered by injection and is typically taken once a day at the same time each day. It works by regulating glucose metabolism in the body and maintaining a more consistent blood sugar level throughout the day.

Toujeo has been approved by the Food and Drug Administration (FDA) for the treatment of both type 1 and type 2 diabetes in adults. It has also been approved for use in children ages six years and older with type 1 diabetes.

Some potential side effects of Toujeo include hypoglycemia (low blood sugar), injection site reactions, allergic reactions, and others. It is important to speak with a healthcare provider before beginning treatment with Toujeo, as well as to closely monitor blood sugar levels and follow dosage instructions carefully.